Burjeel Holdings’s Cancer Care Network: The Future of Oncology in the GCC

Abu Dhabi’s Burjeel Holdings is set to expand its healthcare footprint by establishing a specialist oncology network across the Gulf Cooperation Council (GCC) region. This initiative aims to enhance cancer care accessibility and quality for patients in the UAE and neighboring countries. Overview of Burjeel Holdings Burjeel Holdings, a prominent healthcare provider in the Middle East and North Africa (MENA) region, has made significant strides in oncology care. Its flagship facility, Burjeel Medical City (BMC), is recognized as a Center of Excellence for Oncology Care and has been accredited by the European Society for Medical Oncology (ESMO) as an Integrated Oncology and Palliative Care Center. This accreditation underscores BMC’s commitment to providing comprehensive cancer treatment, including medical, surgical, radiation oncology, and nuclear medicine services. The Need for a Specialist Oncology Network Cancer remains a leading health challenge in the UAE, accounting for approximately 10% of all deaths. The UAE government has set ambitious goals to reduce cancer mortality by nearly 18% by 2025. Despite